about
Plasma PGE-2 levels and altered cytokine profiles in adherent peripheral blood mononuclear cells in non-small cell lung cancer (NSCLC)Medicinal Plants from Mexico, Central America, and the Caribbean Used as ImmunostimulantsInterleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanismSurgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activityApoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cellsRestored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.Targeting transforming growth factor beta to enhance cancer immunotherapy.
P2860
Q24799840-505D232C-1B07-43B4-83A5-BE94D5ECB404Q26752766-D5E3C98F-C1FE-4A73-81D4-8CC7796B1BFBQ34392868-DABDD284-709B-4BF9-97F7-0002420B44EEQ35768107-D6C73721-8924-480A-A06F-FEF0B6443874Q35787792-CCEB5617-76F3-4FB0-9625-33BC9F592748Q35870682-C8403351-A66B-4DFA-A846-47D779DD55F5Q36161355-C9F5A9EB-EAD6-4522-BE7C-A9C04879ECE8Q36259633-7DBCA770-9479-423C-ADED-779B207CA72CQ36291674-9ABA0317-C1BB-4371-9EF2-493D4AD92440Q36454468-5E72EE9B-EF65-4517-ACE5-1A7F9206E674Q36648740-89B5A566-50DD-4D4A-890C-D8F8D866B6AFQ40115182-CCA01DDC-9191-47D8-95E8-C829EA6212E4Q42747896-8ACA1A8E-352E-4E31-A3EB-23ADC756A59C
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Immunosuppressive factors in human cancer.
@en
type
label
Immunosuppressive factors in human cancer.
@en
prefLabel
Immunosuppressive factors in human cancer.
@en
P1476
Immunosuppressive factors in human cancer
@en
P2093
D Sulitzeanu
P304
P577
1993-01-01T00:00:00Z